Prasugrel is a medication used to manage and treat acute coronary syndrome undergoing percutaneous intervention. Prasugrel is a thienopyridine, an irreversible antagonist of the ADP P2Y12 receptor. The antiplatelet effect of prasugrel lasts until the lifespan of platelets. Prasugrel is a prodrug that is converted to an active and inactive metabolite by the hepatic CYP system. This activity covers the indications, dosing, contraindications, mechanism of action, and management of prasugrel in cases where it can provide therapeutic benefit.

**Objectives:**
- Describe the mechanism of action of prasugrel.
- Review the indications of prasugrel.
- Summarize the pharmacokinetics of prasugrel.
- Explain the importance of care coordination amongst the interprofessional team to enhance patient safety for anyone using prasugrel.